Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.880
-0.230 (-7.40%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Genelux Market Cap
Genelux has a market cap or net worth of $107.41 million as of April 25, 2025. Its market cap has decreased by -6.58% in one year.
Market Cap
107.41M
Enterprise Value
78.38M
1-Year Change
-6.58%
Ranking
Category
Stock Price
$2.88
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $107.41M, a decrease of -24.20%. That is a compound annual growth rate of -11.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 107.41M | 33.45% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |